Vera Therapeutics/$VERA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Vera Therapeutics
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
Ticker
$VERA
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
152
ISIN
US92337R1014
Website
VERA Metrics
BasicAdvanced
$2B
-
-$3.00
1.28
-
Price and volume
Market cap
$2B
Beta
1.28
52-week high
$49.23
52-week low
$18.53
Average daily volume
1.8M
Financial strength
Current ratio
27.682
Quick ratio
27.104
Long term debt to equity
9.958
Total debt to equity
10.18
Interest coverage (TTM)
-25.34%
Management effectiveness
Return on assets (TTM)
-23.46%
Return on equity (TTM)
-39.49%
Valuation
Price to book
3.65
Price to tangible book (TTM)
3.65
Price to free cash flow (TTM)
-11.456
Growth
Earnings per share change (TTM)
46.40%
3-year earnings per share growth (CAGR)
8.95%
What the Analysts think about VERA
Analyst ratings (Buy, Hold, Sell) for Vera Therapeutics stock.
VERA Financial Performance
Revenues and expenses
VERA Earnings Performance
Company profitability
VERA News
AllArticlesVideos
Vera Therapeutics to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
GlobeNewsWire·2 days ago
Vera Therapeutics Announces Refinancing of Existing Oxford Debt Facility, Providing up to $500 Million of Term Loans
GlobeNewsWire·3 days ago
Kidney Health-Focused Vera Therapeutics Stock Price Spikes On Heels Of Successful Trial Data
Benzinga·4 days ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Vera Therapeutics stock?
Vera Therapeutics (VERA) has a market cap of $2B as of June 06, 2025.
What is the P/E ratio for Vera Therapeutics stock?
The price to earnings (P/E) ratio for Vera Therapeutics (VERA) stock is 0 as of June 06, 2025.
Does Vera Therapeutics stock pay dividends?
No, Vera Therapeutics (VERA) stock does not pay dividends to its shareholders as of June 06, 2025.
When is the next Vera Therapeutics dividend payment date?
Vera Therapeutics (VERA) stock does not pay dividends to its shareholders.
What is the beta indicator for Vera Therapeutics?
Vera Therapeutics (VERA) has a beta rating of 1.28. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.